MONDAY, Oct. 28, 2024 — The weight-loss drug Ozempic can guard against kidney disease in obese people, a new study shows.
Patients taking semaglutide — the active agent in Ozempic and Wegovy — had as much as a 52% reduction in kidney damage, as…
You may also like
How AI Might Help Men Fighting Prostate Cancer
Iowa Resident Dies of Suspected Lassa Fever After Trip...
AI Might Help Pick Up Heart Trouble in Dogs
Childhood Attention Issues Show Links to Later Risk...
Colonoscopy Still Beats New Blood Tests at Spotting...
More Than Half of Heat Deaths Can Be Blamed on Global...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.